The Food and Drug Administration approved MedImmune?s FluMist vaccine for children as young as 2, the Gaithersburg company announced Wednesday.

Business is looking up for MedImmune, which was acquired by AstraZeneca in June. Also this year, it won approval for a FluMist formula that doesn?t need to be frozen.

Recommended Stories

Options for protection come with flu season

Best hold off on that decongestant

Mistreating livestock can have devastating consequences for people